Hypersensitivity – Talk Bio

Actionable Insights Powered by AI

Novartis and Relation Therapeutics form AI-driven, multi-program atopic disease collaboration

1 day ago talkbio0Tagged * * atopic diseases * *, * * functional cell, AI-powered, Asthma, atlases, Billion, Drug Discovery, Eczema, Hypersensitivity, IL13 gene, immuno-dermatology, Lab-in-the-Loop, milestones, multi-program collaboration, Novartis

Novartis; Relation Therapeutics; AI-powered drug discovery; Lab-in-the-Loop; atopic diseases; immuno-dermatology; multi-program collaboration; asthma; allergies; eczema; allergic rhinitis; $55 million upfront; $1.7 billion milestones; functional cell atlases

Exact Sciences plans ‘transformative year’ with 3 cancer test debuts

7 months ago talkbio0Tagged Exact brand biomedical or dental material, Hypersensitivity, MRD, Science

Science, MRD, Exact brand biomedical or dental material, Hypersensitivity

FDA Adds Boxed Warning to Teva’s Copaxone and Generic Glatopa Due to Anaphylaxis Risk

11 months ago talkbio0Tagged acetate, anaphylaxis, boxed, Cautionary Warning, Copaxone, glatiramer, Glatopa, Hypersensitivity, Multiple Sclerosis, Risk, United States Food and Drug Administration

FDA Boxed Warning, Anaphylaxis Risk, Copaxone, Glatopa, Glatiramer Acetate, Multiple Sclerosis (MS) Treatment, Allergic Reaction

FDA Approves Xolair (Omalizumab) for Reducing Severe Outcomes from Multiple Food Allergies

2 years ago talkbio0Tagged Food, Hypersensitivity, omalizumab, Reduced, Severe (severity modifier), United States Food and Drug Administration, Xolair

Xolair, United States Food and Drug Administration, omalizumab, Hypersensitivity, Food, Reduced, Severe (severity modifier)